Schonfeld Strategic Advisors »

Summit Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $478k 27k 17.49
2024-09-30 $1.2M 56k 21.90
2024-06-30 $171k 22k 7.80
2023-03-31 $83k 48k 1.75

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
Nomura Holdings
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics